Foto del docente

Lorenzo Pelizza

Professore associato

Dipartimento di Scienze Biomediche e Neuromotorie

Settore scientifico disciplinare: MEDS-11/A Psichiatria

Curriculum vitae

Scarica Curriculum Vitae (.pdf 188KB )
ATTIVITA’ FORMATIVA
 Diploma di Laurea in Medicina e Chirurgia c/o la Facoltà di Medicina e Chirurgia dell’Università degli
Studi di Parma
 Diploma di Special izzazione in Psichiatria c/o l’Istituto di Clinica Psichiatrica della Facoltà di Medicina
e Chirurgia dell’ Università degli Studi di Parma
 Diploma di Laurea Magistrale in Psicologia dello Sviluppo c/o la Facoltà di Psicologia dell’ Università
degli Studi d i Parma
 Dottorato di Ricerca in “Neuroscienze clinico sperimentali e Psichiatria curriculum: intervento precoce
negli esordi psicotici e nei disturbi dell’umore ” c/o la Facoltà di Medicina e Chirurgia (Dipartimento di
Neuroscienze) dell’Università degli Studi “La Sapienza” di Roma
 R icercatore a tempo determinato in Psichiatria ” c/o il Dipartimento di Scienze Biomediche e
Neuromotorie dell’Università degli Studi di Bologna.
ATTIVITA’ PROFESSIONALE
 Dirigente medico di psichiatria a tempo determinato pe r l’Azienda Ospedaliera “Isti tuti Ospitalieri” di
Cremona servizio svolto presso l’ SPDC d el presidio o spedaliero “Oglio Po” di Casalmaggiore (
 Dirigente medico di psichiatria a tempo indeterminato per l’AUSL IRCCS di Reggio Emilia (RE) RE),
servizio svol to c/o il CSM di Guastalla (RE) e il C SM “Via Petrella” di Reggio Emilia di cui sono stato
responsabile di unità operativa semplice)
 Dirigente medico di psichiatria a tempo indeterminato p er l’AUSL di Parma PR servizio svolto c/o la
RTI “Santi” di Pa rma, la RTE “I Maggio” di Colorno la REMS di Parma e negli Istituti Penitenziari di
Parma (di cui sono stato responsabile dell’unità operativa semplice
 Dal 2016, membro del gruppo tecnico regionale “ Esordi Psicotici ” della Regione Emilia Romagna.
 A ttualm ente Ricercatore a tempo determionato in Psichiatria presso il Dipartimento di Scienze
Biomediche e Neuromotorie (DIBINEM) dell’Alma M ater Studiorum Università degli Studi di
B ologna , con convenzione all’attività clinica presso l’AUSL di Bologna serviz io svolto presso il CSM
“Saragozza” di Bologna e l’RTI “Arcipelago” di Bologna
PUBBLICAZIONI SCIENTIFICHE
(ultimi 2 anni)
 Pelizza L et al. “Association between case management and longitudinal decrease in negative symptoms in patients
with first episode psychosis: a 2 year follow up”. Early Intervention in Psychiatry 2022, January 18, DOI:
10.1111/eip.13267.
 Pelizza L, Leuci E. Budget di salute negli esordi psicopatologici. In Starace F, Monzani E: Il Budget di salute.
Roma: Carocci, 2022.
2
 Pelizza L et alPelizza L et al. “Association between psychosocial interventions and aberrant salience in adolescents with early . “Association between psychosocial interventions and aberrant salience in adolescents with early psychosis: a followpsychosis: a follow--up study”. Scandinavian Journal of Psychology 2022, March 14, DOI: 10.1111/sjop.12806.up study”. Scandinavian Journal of Psychology 2022, March 14, DOI: 10.1111/sjop.12806.
 Pelizza Pelizza L L et al. “Reliability of the “Parma Scale” et al. “Reliability of the “Parma Scale” for forensic psychiatric treatment evaluation: preliminary findings for forensic psychiatric treatment evaluation: preliminary findings in a sample of prisoners with mental disorder”. Journal of Psychopathology 2022; 28: 94in a sample of prisoners with mental disorder”. Journal of Psychopathology 2022; 28: 94--112.112.
 Pugliese V, Aloi M, …, Pelizza L, SeguraPugliese V, Aloi M, …, Pelizza L, Segura--Garcia C, De Fazio P. “Validation of the Italian versiGarcia C, De Fazio P. “Validation of the Italian version of the Davos on of the Davos Assessment of Cognitive Biases Scale (DACOBS) in a sample of schizophrenia spectrum disorder patients and Assessment of Cognitive Biases Scale (DACOBS) in a sample of schizophrenia spectrum disorder patients and healthy controls”. Rivista di Psichiatria 2022; 57: 127healthy controls”. Rivista di Psichiatria 2022; 57: 127--133.133.
 Pelizza Pelizza L L et al. “Psychometric properties of the Parma Scale for the treaet al. “Psychometric properties of the Parma Scale for the treatment evaluation of offenders with mental tment evaluation of offenders with mental disorder: a new instrument for routine outcome monitoring in forensic psychiatric setting”. disorder: a new instrument for routine outcome monitoring in forensic psychiatric setting”. International Journal of International Journal of Law and Psychiatry 2022; 8: 101828.Law and Psychiatry 2022; 8: 101828.
 Pelizza Pelizza L L et al. “Depressed mood in first episode schizophrenet al. “Depressed mood in first episode schizophrenia: findings from a 1ia: findings from a 1--year followyear follow--up in an Italian realup in an Italian real--world care setting”. Psychiatry: International and Biological Processes 2022; world care setting”. Psychiatry: International and Biological Processes 2022; 4: 14: 1--3; doi: 3; doi: 10.1080/00332747.2022.2120308.10.1080/00332747.2022.2120308.
 Oliva G, Fanelli G, ... and the DOliva G, Fanelli G, ... and the DiAPASon Consortuim (Pelizza L). iAPASon Consortuim (Pelizza L). “Patterns of “Patterns of antipsychotic prescription and antipsychotic prescription and accelerometeraccelerometer--based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study”. International Clinical Psychopharmacology 2022; doi: 10.1097/YIC.0000000000000433.prospective study”. International Clinical Psychopharmacology 2022; doi: 10.1097/YIC.0000000000000433.
 Pelizza L et Pelizza L et al. “Anxiousal. “Anxious--depressive symptoms after a first episode of schizophrenia: response to treatment and depressive symptoms after a first episode of schizophrenia: response to treatment and psychopathological considerations from the 2psychopathological considerations from the 2--year “Parma Early Psychosis” program”. Psychiatry Research 2022; year “Parma Early Psychosis” program”. Psychiatry Research 2022; 317: 114887.317: 114887.
 Poletti M,. Gebhardt E, Pelizza L Poletti M,. Gebhardt E, Pelizza L et al. et al. “Neurodevelopmental antecedents and sensory phenomena in obsessive“Neurodevelopmental antecedents and sensory phenomena in obsessive--compulsive disorder: a systematic review supporting a phenomenologicalcompulsive disorder: a systematic review supporting a phenomenological--developmental model”. Psychopathology developmental model”. Psychopathology 2022; October 25; 2022; October 25; https:https://doi.org/10.1159/000526708//doi.org/10.1159/000526708..
 Pelizza L et al. “Depressed mood in first episode psychosis: findings from the “Parma Early Psychosis” program”. Pelizza L et al. “Depressed mood in first episode psychosis: findings from the “Parma Early Psychosis” program”. Journal of Psychopathology 2022; 28: 179Journal of Psychopathology 2022; 28: 179--187; 187; https://doi.ohttps://doi.org/10.36148/2284rg/10.36148/2284--02490249--464464..
 Pelizza L et al. “The “Parma AtPelizza L et al. “The “Parma At--Risk Mental States” (PARMS) program: general description and process analysis Risk Mental States” (PARMS) program: general description and process analysis after 5 years of clinical activity”. Early Intervention in Psychiatry 2023; Jan 12; after 5 years of clinical activity”. Early Intervention in Psychiatry 2023; Jan 12; https://doi.org/10.1111/eip.13399https://doi.org/10.1111/eip.13399..
 Zarbo C, Stolarski M, …, Pelizza L et al. Zarbo C, Stolarski M, …, Pelizza L et al. “Time perspective affects daily time use and daily functioning in “Time perspective affects daily time use and daily functioning in individuals with schizophrenia spectrum disorders: results from the multicentric DiAPAson study”.individuals with schizophrenia spectrum disorders: results from the multicentric DiAPAson study”. Journal of Journal of Psychiatric Research 2023; February 02; Psychiatric Research 2023; February 02; https://doi.org/10.1016/j.psychires.2023.02.012https://doi.org/10.1016/j.psychires.2023.02.012..
 Pelizza L et al. “Presentation of the “Parma Scale” for treatment evaluation in offenders wPelizza L et al. “Presentation of the “Parma Scale” for treatment evaluation in offenders with mental disorders”. ith mental disorders”. Rassegna Italiana di Psychiatria 2022; 4: 261Rassegna Italiana di Psychiatria 2022; 4: 261--270; 270; https://doi.org/10.7347/RIChttps://doi.org/10.7347/RIC--042022042022--p261p261..
 Pelizza L et al. “Depressive features in individuals with first episode psychosis: psPelizza L et al. “Depressive features in individuals with first episode psychosis: psychopathological and treatment ychopathological and treatment considerations from a 2considerations from a 2--year followyear follow--up study”. Clinical Neuropsychatry 2023;20: 39up study”. Clinical Neuropsychatry 2023;20: 39--47; 47; https://doi.org/10.36131/cnfioritieditore20230105https://doi.org/10.36131/cnfioritieditore20230105..
 Poletti M, Pelizza L Poletti M, Pelizza L et al. et al. “Anhedonia e suicidal ideation in young people with early psychosis: further findings “Anhedonia e suicidal ideation in young people with early psychosis: further findings from the 2from the 2--year followyear follow--up of the ReARMS program”. Psychiatry Research 2023; 323: 115777; up of the ReARMS program”. Psychiatry Research 2023; 323: 115777; https://doi.https://doi.org/10.1016/j.psychres.2023.115177org/10.1016/j.psychres.2023.115177..
 Pelizza L et al. “Longitudinal evaluation on negative symptoms in young people at UltraPelizza L et al. “Longitudinal evaluation on negative symptoms in young people at Ultra--High Risk (UHR) of High Risk (UHR) of psychosis: results from a 2psychosis: results from a 2--year followyear follow--up study in a real world care setting”. European Archives of Psychiatry up study in a real world care setting”. European Archives of Psychiatry and and Clinical Neuroscience 2023; Clinical Neuroscience 2023; https://doi.org/10.1007/s00406https://doi.org/10.1007/s00406--023023--0160001600--22..
3
 Mayeli A, ..., Pelizza L et al. “Shared and distinct abnormalities in sleep-wake patterns and their relationship with
the negative symptoms of schizophrenia spectrum disorder patients”. Molecular Psychiatry 2023;
https://doi.org/10.1038/s41380-023-02050-x.
 Pellegrini P, Paulillo G, …, Pelizza L. “Verso un sistema di cura e giudiziario di comunità”. Rivista Sperimentale di
Freniatria 2023; 2023/1: 49-68. https://doi.org/10.3280/RSF2023-001004.
 Pelizza L et al. “Baseline antipsychotic prescription and short-term outcome indicators in individuals ay clinical
high-risk for psychosis: findings from the Parma At-Risk Mental States (PARMS) program”. Early Intervention in
Psychiatry 2023; https://doi.org/10.1111/eip.13434.
 Belvederi Murri M, Ferrara M, ... Pelizza L, et al. “A public early intervention approach to first-episode psychosis:
treated incidence over 7 years in the Emilia-Romagna region”. Early Intervention in Psychiatry 2023;
https://doi.org/10.1111/eip.13437.
 Pelizza L et al. “Is depressed mood clinically relevant at the onset of schizophrenia? A longitudinal study”. Archives
of Psychiatry and Psychotherapy 2023; 2: 15-24. https://doi.org/10.12740/APP/158201.

Ultimi avvisi

Al momento non sono presenti avvisi.